Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2007 1
2008 4
2009 5
2010 2
2011 3
2012 4
2013 2
2014 6
2015 4
2016 2
2017 1
2018 2
2019 3
2020 6
2021 6
2022 5
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

49 results

Results by year

Filters applied: . Clear all
Page 1
Paediatric-type diffuse high-grade gliomas in the 5th CNS WHO Classification.
Gianno F, Giovannoni I, Cafferata B, Diomedi-Camassei F, Minasi S, Barresi S, Buttarelli FR, Alesi V, Cardoni A, Antonelli M, Puggioni C, Colafati GS, Carai A, Vinci M, Mastronuzzi A, Miele E, Alaggio R, Giangaspero F, Rossi S. Gianno F, et al. Pathologica. 2022 Dec;114(6):422-435. doi: 10.32074/1591-951X-830. Pathologica. 2022. PMID: 36534421 Free PMC article. Review.
Optimizing biomarkers for accurate ependymoma diagnosis, prognostication, and stratification within International Clinical Trials: A BIOMECA study.
Chapman RJ, Ghasemi DR, Andreiuolo F, Zschernack V, Espariat AT, Buttarelli FR, Giangaspero F, Grill J, Haberler C, Paine SML, Scott I, Jacques TS, Sill M, Pfister S, Kilday JP, Leblond P, Massimino M, Witt H, Modena P, Varlet P, Pietsch T, Grundy RG, Pajtler KW, Ritzmann TA. Chapman RJ, et al. Among authors: buttarelli fr. Neuro Oncol. 2023 Oct 3;25(10):1871-1882. doi: 10.1093/neuonc/noad055. Neuro Oncol. 2023. PMID: 36916248 Free PMC article.
Optimizing reirradiation for relapsed medulloblastoma: identifying the ideal patient and tumor profiles.
Massimino M, Vennarini S, Buttarelli FR, Antonelli M, Colombo F, Minasi S, Pecori E, Ferroli P, Giussani C, Schiariti M, Schiavello E, Biassoni V, Erbetta A, Chiapparini L, Nigro O, Boschetti L, Gianno F, Miele E, Modena P, De Cecco L, Pollo B, Barretta F. Massimino M, et al. J Neurooncol. 2023 Jul;163(3):577-586. doi: 10.1007/s11060-023-04361-z. Epub 2023 Jun 16. J Neurooncol. 2023. PMID: 37326761
Intracranial ependymoma: factors affecting outcome.
Massimino M, Buttarelli FR, Antonelli M, Gandola L, Modena P, Giangaspero F. Massimino M, et al. Among authors: buttarelli fr. Future Oncol. 2009 Mar;5(2):207-16. doi: 10.2217/14796694.5.2.207. Future Oncol. 2009. PMID: 19284379 Review.
Correlation Between Immunohistochemistry and Sequencing in H3G34-Mutant Gliomas.
Gianno F, Antonelli M, Di Dio T, Minasi S, Donofrio V, Buccoliero AM, Gardiman MP, Pollo B, Diomedi Camassei F, Rossi S, Novello M, Giangaspero F, Arcella A, Gessi M, Buttarelli FR. Gianno F, et al. Among authors: buttarelli fr. Am J Surg Pathol. 2021 Feb 1;45(2):200-204. doi: 10.1097/PAS.0000000000001571. Am J Surg Pathol. 2021. PMID: 33428336
Neuropharmacology and behavior in planarians: translations to mammals.
Buttarelli FR, Pellicano C, Pontieri FE. Buttarelli FR, et al. Comp Biochem Physiol C Toxicol Pharmacol. 2008 May;147(4):399-408. doi: 10.1016/j.cbpc.2008.01.009. Epub 2008 Feb 1. Comp Biochem Physiol C Toxicol Pharmacol. 2008. PMID: 18294919 Review.
Pre- and Post-Zygotic TP53 De Novo Mutations in SHH-Medulloblastoma.
Azzollini J, Schiavello E, Buttarelli FR, Clerici CA, Tizzoni L, Vecchi G, Capra F, Pisati F, Biassoni V, Runza L, Carrabba G, Giangaspero F, Massimino M, Pensotti V, Manoukian S. Azzollini J, et al. Cancers (Basel). 2020 Sep 3;12(9):2503. doi: 10.3390/cancers12092503. Cancers (Basel). 2020. PMID: 32899294 Free PMC article.
Treatment and outcome of intracranial ependymoma after first relapse in the 2nd AIEOP protocol.
Massimino M, Barretta F, Modena P, Johann P, Ferroli P, Antonelli M, Gandola L, Garrè ML, Bertin D, Mastronuzzi A, Mascarin M, Quaglietta L, Viscardi E, Sardi I, Ruggiero A, Boschetti L, Giagnacovo M, Biassoni V, Schiavello E, Chiapparini L, Erbetta A, Mussano A, Giussani C, Mura RM, Barra S, Scarzello G, Scimone G, Carai A, Giangaspero F, Buttarelli FR. Massimino M, et al. Neuro Oncol. 2022 Mar 12;24(3):467-479. doi: 10.1093/neuonc/noab230. Neuro Oncol. 2022. PMID: 34605902 Free PMC article.
High-throughput microRNA profiling of pediatric high-grade gliomas.
Miele E, Buttarelli FR, Arcella A, Begalli F, Garg N, Silvano M, Po A, Baldi C, Carissimo G, Antonelli M, Spinelli GP, Capalbo C, Donofrio V, Morra I, Nozza P, Gulino A, Giangaspero F, Ferretti E. Miele E, et al. Neuro Oncol. 2014 Jan;16(2):228-40. doi: 10.1093/neuonc/not215. Epub 2013 Dec 4. Neuro Oncol. 2014. PMID: 24305714 Free PMC article.
NSD1 Mutations and Pediatric High-Grade Gliomas: A Comparative Genomic Study in Primary and Recurrent Tumors.
d'Amati A, Nicolussi A, Miele E, Mastronuzzi A, Rossi S, Gianno F, Buttarelli FR, Minasi S, Lodeserto P, Gardiman MP, Viscardi E, Coppa A, Donofrio V, Giovannoni I, Giangaspero F, Antonelli M. d'Amati A, et al. Diagnostics (Basel). 2022 Dec 27;13(1):78. doi: 10.3390/diagnostics13010078. Diagnostics (Basel). 2022. PMID: 36611369 Free PMC article.
49 results